Search results
Calafiori BOOST, Rabiot FREE, Kelleher U-TURN, Summer CLEAROUT - Liverpool FC news recap
Anfield Watch· 4 days agoLiverpool are only in for one player during the summer transfer window - Lille centre back Leny Yoro...
In Pics: Fan of Furiosa - A Mad Max Saga? Here are 10 other action movies you can watch
Mid Day· 4 days agoIn present-day London, a 12-year-old named Quinn Abercromby witnesses a hibernating dragon awakening...
UK General Elections Live Updates: Labour Tipped For Historic Sweep As UK Goes To Polls
NDTV· 3 days agoHere are some of the key numbers as UK voters go to the polls Thursday in a general election...
Fictional Presidents on Film: A Look at 10 of the Best
First for Women· 4 days agoFictional presidents on film, they've been played by people like Harrison Ford, Kevin Kline, Michael...
Exploring Robert Pattinson And Suki Waterhouse's Relationship Timeline As The Couple Became Parents
Koimoi· 2 days agoTwilight star Robert Pattinson and his fiance Suki Waterhouse began dating in 2018 and has recently...
€45m winger could be the budget option of Chelsea’s dreams after double transfer fail
The Chelsea News· 3 days agoChelsea’s attempts to sign a right winger have been a notable feature of this summer so far.The...
Sources: Chelsea agree £30m deal for Dewsbury-Hall
ESPN· 6 days agoChelsea are set to sign Leicester City midfielder Kiernan Dewsbury-Hall after agreeing a £30 million ($38m) fee, sources have told ESPN. The 25-year-old...
India's on top, South Africa's latest 'choke' headline global reactions | Cricket News - Times of...
The Times of India· 6 days agoNEW DELHI: The global press lauded India's remarkable victory in the T20 World Cup final on Sunday....
Wimbledon PIX: Zverev, Djokovic, Rune cruise through
rediff.com· 2 days agoIMAGE: Germany’s Alexander Zverev proved too strong for Marcos Giron of the United States to reach the Wimbledon third round, where he will face Briton...
Left in limbo: When pharma halts rare disease research
Pharmaceutical Technology· 4 days agoTerry Pirovolakis started Elpida Therapeutics, a not-for-profit biotech, after his son Michael was...